Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Sedgwick SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your facility at 1234 Industrial Pkwy received EPA violation #2024-XYZ on March 15th" (government database with record number)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
These messages are ordered by quality score. The best plays come first, regardless of whether they use public, internal, or hybrid data sources.
Target medical device or pharmaceutical manufacturers who received FDA warning letters. Map their at-risk product lines and build a complete customer notification tree showing who needs to be contacted and in what order.
This play delivers immediate strategic value: the notification tree with account counts and sequencing strategy they can use whether they hire you or not.
The specificity is stunning - 14 SKUs, 2,847 accounts, 18,300 end-users. This isn't a pitch, it's pre-completed work.
The strategic insight about "who reports first" addresses a critical brand reputation concern. This demonstrates deep understanding of recall mechanics that competitors can't replicate without doing the same analysis.
This play requires Sedgwick's internal database of recall notification patterns from managing 7,000+ recalls, including product distribution mapping methodologies and notification sequencing strategies.
Combined with public FDA warning letter details. This synthesis is unique to Sedgwick's recall management expertise.Target coal mine operators with multiple facilities simultaneously approaching MSHA's pattern of violations (POV) threshold. The play demonstrates portfolio-level risk analysis that individual mine managers may not have visibility into.
This works because it shows cross-facility pattern recognition that the company's own safety teams might miss when focused on individual sites.
The portfolio view (Pike County: 4, Harlan County: 3, Bell County: 4) demonstrates you analyzed their entire operation, not just one facility.
The insight about "compounding scrutiny" when multiple sites approach POV simultaneously is non-obvious and genuinely valuable. This triggers an "oh shit" moment for whoever oversees safety across locations.
Analyze MSHA violation reports across multiple facilities owned by the same operator to identify systemic engineering issues. When the same violation type appears across different sites, it signals a corporate-level problem rather than site-specific failures.
Deliver a root cause hypothesis based on actual inspection report analysis - this is actionable intelligence they can use immediately.
The "not coincidence" framing is bold and attention-grabbing. Identifying the same violation pattern (ventilation systems) across 3 facilities within 60 days demonstrates you actually read the inspection reports, not just pulled violation counts.
The systemic engineering issue insight elevates the conversation from site-level operations to corporate safety strategy. This lands on the desk of the VP of Safety, not just mine managers.
Target coal mines that are one violation away from MSHA's pattern of violations (POV) threshold. This creates urgency because POV status triggers mandatory safety conferences and potential closure orders.
The specificity of counting violations for them (4 of 5) demonstrates active monitoring and creates a sense of "someone is paying attention to this."
The POV threshold is a concrete regulatory trigger with severe consequences (closure orders). Counting the violations for them (4 of 5, one away) makes the urgency visceral.
Specific location (Pike County KY), date (Dec 3), and violation types (ventilation and roof control) prove this isn't a template. The question about tracking/coordination addresses an operational gap they likely have.
Target large manufacturers or industrial companies with multiple facilities. Cross-reference EPA ECHO and OSHA databases to identify facilities with violations from both agencies within 30 days of each other.
This portfolio-level analysis reveals systemic compliance gaps that corporate risk managers need to see but often don't have visibility into.
The portfolio scope (12 facilities) demonstrates enterprise-level analysis. Highlighting 3 facilities "in escalation zones" with joint enforcement notices creates immediate urgency.
The deliverable (facility list with abatement deadlines) is concrete and actionable. This non-obvious synthesis across properties is exactly what VP of Risk Management needs but doesn't have time to compile themselves.
Target pharmaceutical and medical device manufacturers who received FDA warning letters for sterile manufacturing violations. Use historical data to show that warning letters are leading indicators of recalls within 180 days.
The timeline pressure (day 45 of 180) creates urgency while the 62% recall conversion rate makes the risk concrete.
The specific date (Nov 14) and violation type (CGMP in sterile manufacturing) prove you read their actual warning letter. The 62% stat backed by 2019-2024 data is powerful and credible.
Timeline pressure (day 45 of 180) creates urgency without being alarmist. The question assumes sophistication (recall team exists) which flatters rather than condescends. This is genuinely non-obvious insight about warning letter trajectories.
Similar to the Pike County play but with emphasis on the 90-day rolling window. Track coal mines with 4 S&S violations since a specific start date to show they're approaching the POV threshold within MSHA's calculation period.
The focus on "mandatory safety conferences and potential closure orders" makes the consequences concrete.
Strong urgency (1 away from threshold). Specific timeframe (since Sept 5, 90-day window) shows you understand MSHA's calculation methodology.
POV consequences are concrete and scary (closure orders). The question about coordinating with MSHA on abatement timeline is appropriate and shows understanding of the regulatory process.
Target pharmaceutical manufacturers with FDA warning letters that cite multiple product lines. Read the actual warning letter to count specific product lines mentioned, then demonstrate understanding of how recall complexity varies by product type.
The insight about ophthalmics having 4x the notification burden of injectables shows deep domain expertise.
Specific product line count (8) from actual letter proves you read it carefully. The ophthalmics vs injectables comparison (4x notification burden) is insightful and demonstrates specialized knowledge.
The question addresses prioritization strategy, which is genuinely valuable - they probably haven't thought through which lines to address first. This is non-obvious synthesis of the warning letter that adds strategic value.
Target manufacturing facilities with EPA and OSHA violations within the same 30-day window. The dual enforcement signals systemic safety/compliance failures that create compounded regulatory liability.
The penalty multiplier insight (willful classification at $156K per violation) makes the financial risk concrete.
Specific facility address (1234 Industrial Blvd) and dates (Oct 15, Oct 22) establish credibility. Quantified penalty risk ($156K) makes it concrete.
The "joint enforcement increases penalty multipliers" angle is non-obvious and valuable. Easy routing question. They demonstrated cross-agency data synthesis that most vendors wouldn't bother with.
Target pharmaceutical and medical device manufacturers with FDA warning letters for sterile CGMP violations. Emphasize the timeline countdown (day 45 of 180-day typical window before recalls) to create urgency.
The 62% recall conversion rate based on 2019-2024 data makes the risk quantifiable.
Timeline countdown (day 45) creates urgency. Specific violation type and data range (2019-2024) make the 62% stat credible.
The question about recall prep is appropriate and assumes they need it (maybe presumptuous but acceptable given the data). Similar to the other warning letter variant but slightly weaker execution.
Target manufacturers with FDA warning letters. Model recall cost scenarios using Sedgwick's internal database of 340+ similar recalls to provide median cost estimates by product type and violation category.
The deliverable (cost breakdown by recall scope) offers planning value whether they engage or not.
Uses their specific warning letter as anchor point. The $4.7M median cost is specific and scary. Claims proprietary database (340 recalls) though hard to verify.
The deliverable (cost breakdown by recall scope) is concrete. However, this edges toward industry benchmarks dressed up as insight - it somewhat fails the competitor test as other recall management firms could send similar data.
This play requires Sedgwick's internal database of recall costs from 340+ managed events, segmented by product type, violation category, and recall scope (median costs across notification, logistics, inventory replacement).
This is proprietary data only Sedgwick has from managing thousands of recalls.Target manufacturers with multiple facilities facing dual EPA-OSHA enforcement within 30 days. Build a consolidated response strategy showing optimal abatement sequencing to minimize penalty exposure across all sites.
The portfolio scope (3 facilities) demonstrates enterprise-level thinking.
Multi-facility scope shows portfolio thinking. The EPA-OSHA coordination insight about penalty negotiations is valuable.
However, the deliverable is vague - what's actually in the roadmap? Feels like consulting pitch, not immediate value. Doesn't pass "actionable without reply" test. Would need more specificity to be truly strong.
This play requires Sedgwick's internal playbooks for coordinated EPA-OSHA enforcement responses, including penalty negotiation frameworks and multi-site compliance sequencing strategies.
Combined with public violation data to create facility-specific roadmaps.Target coal mines approaching MSHA's pattern of violations threshold. Map violation patterns across 84 days to identify high-risk systems likely to trigger the 5th citation that would push them into POV status.
Offer a playbook covering inspection timing, abatement sequencing, and MSHA conference preparation.
Specific facility (Pike County) and timeframe (84 days) establish credibility. The "3 high-risk systems" claim is interesting but unverified.
The playbook sounds valuable but what's actually in it? This is more consulting/advisory than data insight. Doesn't give them anything actionable without a call. Would need more specificity about the deliverable.
This play requires Sedgwick's internal knowledge base from managing coal mine claims, including pattern analysis capabilities and POV avoidance playbooks with inspection timing and abatement sequencing strategies.
Combined with public MSHA violation data to identify high-risk systems.Target facilities with overlapping EPA and OSHA violation abatement deadlines. Build a coordination timeline showing both agencies' inspection schedules, penalty escalation triggers, and optimal response sequencing.
The "dual-track roadmap" positions Sedgwick as coordination experts.
Specific to their facility and dates (Oct 15, Oct 22). The "dual-track roadmap" sounds valuable.
But what exactly is in it? Too vague about deliverable. This feels like a consulting pitch, not a data insight. Doesn't pass "so what" test - not actionable without meeting. Needs more concrete preview of the actual value.
This play requires Sedgwick's internal templates and playbooks for dual EPA-OSHA enforcement coordination, including inspection schedule tracking, penalty escalation triggers, and response sequencing frameworks.
Combined with public violation and abatement deadline data.Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your Dallas facility has EPA and OSHA violations from October" instead of "I see you're hiring for safety roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable public data or proprietary internal databases. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| EPA ECHO Database | facility_name, facility_address, violation_count, inspection_date, violation_type | Identifying manufacturing facilities with environmental compliance violations and enforcement actions |
| OSHA Inspections Database | establishment_name, establishment_address, inspection_date, citation_count, citation_severity, penalty_amount | Finding facilities with workplace safety violations and serious citations |
| FDA Warning Letters Database | facility_name, warning_date, violation_type, warning_scope (full text) | Identifying pharmaceutical and medical device manufacturers with compliance issues that predict recalls |
| FDA Recalls Database | company_name, product_name, recall_date, hazard_description, units_affected | Calculating warning letter to recall conversion rates and recall patterns |
| MSHA Mine Safety Database | mine_name, mine_id, violation_count, accident_count, injury_frequency_rate, inspection_date | Tracking coal mine operators approaching pattern of violations (POV) thresholds |
| Internal Recall Database | Product distribution patterns, notification trees, cost profiles by recall scope, timing roadmaps | Modeling recall scenarios and building customer notification strategies (7,000+ managed recalls) |
| Internal Compliance Playbooks | Dual-enforcement coordination templates, penalty negotiation frameworks, abatement sequencing strategies | Building consolidated response strategies for multi-agency enforcement scenarios |
| Internal Claims Database | Pattern analysis from managed claims, POV avoidance strategies, MSHA conference prep templates | Identifying systemic safety issues across multiple facilities and predicting high-risk systems |